Hirose S, Jaggi U, Wang S, Tormanen K, Nagaoka Y, Katsumata M
Invest Ophthalmol Vis Sci. 2020; 61(6):20.
PMID: 32516406
PMC: 7415293.
DOI: 10.1167/iovs.61.6.20.
Matundan H, Mott K, Ghiasi H
J Virol. 2014; 88(14):8016-27.
PMID: 24807710
PMC: 4097799.
DOI: 10.1128/JVI.00913-14.
Takeshita T, Watanabe W, Toyama S, Hayashi Y, Honda S, Sakamoto S
Evid Based Complement Alternat Med. 2013; 2013:698206.
PMID: 24250719
PMC: 3819786.
DOI: 10.1155/2013/698206.
Shimizu T, Takeshita Y, Takamori Y, Kai H, Sawamura R, Yoshida H
Evid Based Complement Alternat Med. 2011; 2011:976196.
PMID: 21716710
PMC: 3118910.
DOI: 10.1155/2011/976196.
Thackray A, Bujdoso R
J Virol. 2002; 76(5):2498-509.
PMID: 11836428
PMC: 153799.
DOI: 10.1128/jvi.76.5.2498-2509.2002.
Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice.
LeBlanc R, Pesnicak L, Cabral E, Godleski M, Straus S
J Virol. 1999; 73(10):8145-51.
PMID: 10482564
PMC: 112831.
DOI: 10.1128/JVI.73.10.8145-8151.1999.
Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney Jr J, Nobusawa E, Brehm M, Bonneau R, Mylin L, Fu T
J Virol. 1998; 72(12):9567-74.
PMID: 9811690
PMC: 110466.
DOI: 10.1128/JVI.72.12.9567-9574.1998.
Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections.
Carr J, Rogerson J, Mulqueen M, Roberts N, Booth R
J Virol. 1997; 71(10):7799-803.
PMID: 9311865
PMC: 192132.
DOI: 10.1128/JVI.71.10.7799-7803.1997.
Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.
Brehm M, Bonneau R, Knipe D, Tevethia S
J Virol. 1997; 71(5):3534-44.
PMID: 9094625
PMC: 191500.
DOI: 10.1128/JVI.71.5.3534-3544.1997.
Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.
Thackray A, FIELD H
Antimicrob Agents Chemother. 1996; 40(4):846-51.
PMID: 8849238
PMC: 163217.
DOI: 10.1128/AAC.40.4.846.
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
Ghiasi H, Kaiwar R, Nesburn A, Slanina S, Wechsler S
J Virol. 1994; 68(4):2118-26.
PMID: 8138996
PMC: 236686.
DOI: 10.1128/JVI.68.4.2118-2126.1994.
Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
FIELD H, Tewari D, Sutton D, Thackray A
Antimicrob Agents Chemother. 1995; 39(5):1114-9.
PMID: 7625798
PMC: 162693.
DOI: 10.1128/AAC.39.5.1114.
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity.
Nash A, Gell P, Wildy P
Immunology. 1981; 43(1):153-9.
PMID: 7251047
PMC: 1555179.
Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy.
FIELD H
Antimicrob Agents Chemother. 1982; 21(5):744-52.
PMID: 7103454
PMC: 182005.
DOI: 10.1128/AAC.21.5.744.
Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
Darby G, Churcher M, Larder B
J Virol. 1984; 50(3):838-46.
PMID: 6328014
PMC: 255744.
DOI: 10.1128/JVI.50.3.838-846.1984.
Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice.
Rouse B, Wagner H
Immunology. 1984; 51(1):57-64.
PMID: 6317545
PMC: 1454414.
Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.
Larsen H, Russell R, Rouse B
Infect Immun. 1983; 41(1):197-204.
PMID: 6305838
PMC: 264763.
DOI: 10.1128/iai.41.1.197-204.1983.
Cell-mediated immunity in mice with primary, secondary and latent herpes simplex virus infection.
Darville J, Blyth W
Arch Virol. 1982; 74(2-3):135-44.
PMID: 6299234
DOI: 10.1007/BF01314707.
A non-lethal test of the resistance of inbred mice to herpes simplex virus type 1.
Collier L, Scott Q
J Hyg (Lond). 1982; 89(2):335-45.
PMID: 6290567
PMC: 2134214.
DOI: 10.1017/s002217240007087x.
Experimental infection and immune response of guinea pigs with varicella-zoster virus.
Matsunaga Y, Yamanishi K, Takahashi M
Infect Immun. 1982; 37(2):407-12.
PMID: 6288560
PMC: 347548.
DOI: 10.1128/iai.37.2.407-412.1982.